Skip to content
10-Q

Quarterly Report

ANAPTYSBIO, INC ANAB

0001370053-25-000089

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 27.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 29.02M sh
Shares Diluted Q3 2025 · Sep 30, 2025 29.09M sh
Shares Diluted Q3 2025 · Sep 30, 2024 28.89M sh
Shares Diluted Q3 2025 · Sep 30, 2024 27.69M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $65.24M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $86K
Capex Q3 2025 · Sep 30, 2024 $95K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$78.3M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$68.67M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $109.83M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $123.08M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$29.42M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$44.73M
Stockholders Equity Q3 2025 · Mar 31, 2025 $34.02M
Stockholders Equity Q3 2025 · Dec 31, 2024 $70.87M
Stockholders Equity Q3 2025 · Sep 30, 2024 $84.37M
Stockholders Equity Q3 2025 · Jun 30, 2024 $9.88M
Stockholders Equity Q3 2025 · Mar 31, 2024 $47.78M
Stockholders Equity Q3 2025 · Dec 31, 2023 $88.1M
Current Liabilities Q3 2025 · Sep 30, 2025 $38.1M
Current Liabilities Q3 2025 · Dec 31, 2024 $45.43M
Current Assets Q3 2025 · Sep 30, 2025 $330.65M
Current Assets Q3 2025 · Dec 31, 2024 $431.88M
Total Assets Q3 2025 · Sep 30, 2025 $353.1M
Total Assets Q3 2025 · Dec 31, 2024 $483.83M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.52
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.16
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.14
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.46
Eps Basic Q3 2025 · Sep 30, 2025 $0.54
Eps Basic Q3 2025 · Sep 30, 2025 −$2.16
Eps Basic Q3 2025 · Sep 30, 2024 −$1.14
Eps Basic Q3 2025 · Sep 30, 2024 −$4.46
Sga Expense Q3 2025 · Sep 30, 2025 $10.21M
Sga Expense Q3 2025 · Sep 30, 2025 $34.95M
Sga Expense Q3 2025 · Sep 30, 2024 $10.56M
Sga Expense Q3 2025 · Sep 30, 2024 $32.2M
Rd Expense Q3 2025 · Sep 30, 2025 $31.41M
Rd Expense Q3 2025 · Sep 30, 2025 $110.41M
Rd Expense Q3 2025 · Sep 30, 2024 $42.21M
Rd Expense Q3 2025 · Sep 30, 2024 $121.25M
Net Income Q3 2025 · Sep 30, 2025 $15.11M
Net Income Q3 2025 · Sep 30, 2025 −$62.85M
Net Income Q3 2025 · Jun 30, 2025 −$38.63M
Net Income Q3 2025 · Mar 31, 2025 −$39.33M
Net Income Q3 2025 · Sep 30, 2024 −$32.85M
Net Income Q3 2025 · Sep 30, 2024 −$123.45M
Net Income Q3 2025 · Jun 30, 2024 −$46.66M
Net Income Q3 2025 · Mar 31, 2024 −$43.94M
Operating Income Q3 2025 · Sep 30, 2025 $34.7M
Operating Income Q3 2025 · Sep 30, 2025 −$19.01M
Operating Income Q3 2025 · Sep 30, 2024 −$22.76M
Operating Income Q3 2025 · Sep 30, 2024 −$105.28M
Revenue Q3 2025 · Sep 30, 2025 $76.32M
Revenue Q3 2025 · Sep 30, 2025 $126.35M
Revenue Q3 2025 · Sep 30, 2024 $30.02M
Revenue Q3 2025 · Sep 30, 2024 $48.17M